Changed date for BioGaia's Year-end report

(Thomson Reuters ONE) - BioGaia's Year-end report 2009 will be published on 22 February 2010instead of on 18 February as was previous announced.Latest press releases from BioGaia:2009-12-08 BioGaia nominates two Executive Vice Presidents2009-10-22 Interim report 1 January - 30 September 20092009-10-08 BioGaia agreement for DenmarkFor additional information contact:Peter Rothschild, President, telephone: +46 8 -555 293 00Jan Annwall, Executive Vice President, telephone: +46 8-555 293 00BioGaia is a biotechnology company that develops, markets and sellsprobiotic productswith documented health benefits. The products are primarily based onthe lactic acidbacterium Lactobacillus reuteri (Reuteri), which has probiotic,health-enhancing effects.The class B share of the Parent Company BioGaia AB is quoted on theSmall Cap listof the NASDAQ OMX Nordic Exchange Stockholm.www.biogaia.comhttp://hugin.info/86913/R/1360030/331749.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 09.12.2009 - 09:24 Uhr
Sprache: Deutsch
News-ID 9421
Anzahl Zeichen: 0

contact information:
Town:

London

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 477 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Changed date for BioGaia's Year-end report"
steht unter der journalistisch-redaktionellen Verantwortung von

BioGaia AB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

BioGaia nominates two Executive Vice Presidents ...

The board of BioGaia has nominated Margareta Hagman and Urban Strindlöv as Executive Vice Presidents of the company as of April 1, 2010. Margareta is responsible for accounting, finance and administration whilst Urban is responsible for product deve ...

Interim report 1 January - 30 September 2009 ...

Interim report 1 January - 30 September 2009 - Net sales amounted to SEK 151.2 million (106.0), an increase of SEK 45.2 million (43%). - Operating profit was SEK 36.4 million (18.4), an increase of SEK 18 million. - Profit before tax was SEK 42.6 ...

BioGaia Agreement for Denmark ...

BioGaia has signed an agreement with the Danish company Pharma Nord Aps, which gives Pharma Nord exclusive rights to sell BioGaia's Probiotic tablets and drops in Denmark. Pharma Nord is one of Europe's largest producers of natural remedi ...

Alle Meldungen von BioGaia AB